KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a recent decision by the Singapore International Commercial Court ("SICC"), which granted an injunction sought by Novo ...

Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being ...

Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...

Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ETCompany ParticipantsYvonne Briggs - Alliance Advisors IRDr.

Reported positive interim pharmacokinetic ("PK") and safety data in Phase 1 trial of SPY001 in November 2024 and strengthened the balance sheet with a $230 million ...

Operator Good afternoon, and welcome to AbCellera's full-year 2024 business update conference call. My name is Tamia, and I will facilitate the audio portion of today's interactive broadcast.

Deaths occurred soon after illness onset and mainly occurred in one village, with younger men disproportionately affected.

Here is a brief rundown of some coming entertainment options in Northeast Ohio. Make submissions for consideration via email to [email protected] or [email protected]. You ...

The GMKtec EVO X1 mini PC combines portability and power with 32GB RAM, 4K HDR support, and a gaming-optimized Linux-based OS ...

The next series by Cowboy Bebop creator Shinichiro Watanabe will be released in a few weeks, with an intriguing plot about a ...